Selecting Sites For Storage Facilities: Supplement 1
Selecting Sites For Storage Facilities: Supplement 1
Selecting Sites For Storage Facilities: Supplement 1
May 2015
2
WHO Technical Report Series, No. 992, Annex 5
Supplement 1
Abbreviations
GIS geographical information system
TTSPP time- and temperature-sensitive pharmaceutical product
3
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Acknowledgements
The author of this document is Andrew Garnett, an independent consultant,
London, England.
4
WHO Technical Report Series, No. 992, Annex 5
Supplement 1
Glossary
Bunding or bund wall: A constructed retaining wall or earth embankment
designed to prevent inundation or breaches from a known source.
Drainage swale: Shallow, sloped channels designed to collect and move surface
run-off toward streets or holding ponds and away from buildings or houses.
Inventory turnover: A measure of the number of times inventory is sold or used
in a time period such as a year. The equation for inventory turnover equals the
cost of goods sold divided by the average inventory. Inventory turnover is also
known as inventory turns, stockturn, stock turns, turns, and stock turnover.
Pharmaceutical product: Any product intended for human use or veterinary
product intended for administration to food producing animals, presented in
its finished dosage form, that is subject to control by pharmaceutical legislation
in either the exporting or the importing state and includes products for which
a prescription is required, products which may be sold to patients without a
prescription, biologicals and vaccines. Medical devices are not included.1
Standard operating procedure (SOP): A set of instructions having the force
of a directive, covering those features of operations that lend themselves to a
definite or standardized procedure without loss of effectiveness. Standard
operating policies and procedures can be effective catalysts to drive performance
improvement and improve organizational results.
Time- and temperature-sensitive pharmaceutical product (TTSPP): Any
pharmaceutical good or product which, when not stored or transported within
predefined environmental conditions and/or within predefined time limits, is
degraded to the extent that it no longer performs as originally intended.
Definition from WHO/QAS/08.252 Rev 1 Sept 2009. Proposal for revision of WHO good distribution practices
1
1. Introduction
This technical supplement has been written to amplify the recommendations
given in Section 2 of WHO Technical Report Series No.961, 2011, Annex 9:
Model guidance for the storage and transport of time- and temperature-sensitive
pharmaceutical products.2 Related topics are covered in the following supplements:
Estimating the capacity of storage facilities
Design of storage facilities
Security and fire protection in storage facilities
1.1 Requirements
Pharmaceutical warehouse sites and other places, such as pharmacies, where
significant quantities of pharmaceutical products are stored, should be located
so as to minimize risks from natural hazards such as floods, landslides and
earthquakes and extreme weather conditions such as hurricanes and tornadoes.
In addition, sites should be located in places that enable the target population to
be served efficiently by making effective use of existing transport infrastructure.
1.2 Objectives
The objective of this Technical Supplement is to provide guidance on how to
meet the above requirements. This document only covers the process of choosing
suitable warehouse locations; it does not cover warehouse sizing or the layout and
development of the site itself for these topics, refer to the companion Technical
Supplements listed above.
http://apps.who.int/medicinedocs/documents/s18683en/s18683en.pdf
2
6
WHO Technical Report Series, No. 992, Annex 5
Supplement 1
2. Guidance
The correct choice of warehouse site(s) and the associated pre-development site
investigation process is a critical strategic decision for any logistics operation.
The goal of supply chain system design is to minimize whole system inventory
holding and distribution costs while ensuring an acceptable service level for
patients and end-users. The overall efficiency of storage and distribution systems
is a major driver for commercial organizations; consequently there is a large
literature on this subject and much professional expertise. This supplement
provides a simple introduction to some of the concepts involved and outlines
some of the key decisions that need to be made.
Related topics are covered in the following supplements:
Design of storage facilities
Estimating warehouse storage capacity
Security and fire protection in storage facilities
Maintenance of storage facilities
Figure 1
Total logistics costs and component cost elements
Extracted from Chapter 8, Figure 8.7 in Rushton, Croucher & Baker (2006).
3
http://hermes.psc.edu/
4
9
WHO Expert Committee on Specifications for Pharmaceutical Preparations
chain costs and the operational factors that drive these costs in a pre-existing
context.5 Commercial consultancies and commercial software are also widely
available to handle these modelling problems.
5
McCord, Tien & Sarley (2013) (http://deliver.jsi.com/dlvr_content/resources/allpubs/guidelines/
SuppChaiCostMeth.pdf ).
6
http://www.google.co.uk/intl/en_uk/earth/download/ge/agree.html
7
http://www.apple.com/uk/ios/maps/
8
For Google Earth, typically between 6 months and 3 years or more: http://www.gearthblog.com/blog/
archives/2010/10/how_often_does_google_update_the_im.html
10
WHO Technical Report Series, No. 992, Annex 5
Supplement 1
Warehouses have large roof areas, so rainwater harvesting combined with on-site storage may be one
9
eruptions and tidal waves are unpredictable and catastrophic events, which
cannot be fully protected against at the level of an individual site. However, it
should be possible to avoid locations that are close to known risks of this type.
http://en.wikipedia.org/wiki/Radon
10
13
WHO Expert Committee on Specifications for Pharmaceutical Preparations
and electrical services engineer. Checks should be carried out to determine the
presence of hazardous materials, such as asbestos.
11
The WHO document: PQS solar autonomy calculation method includes a substantial database of solar
radiation data (http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/
catdocumentation.aspx?id_cat=17).
12
It is essential that wind turbines are installed on sites where there are no nearby buildings or trees; as a
general rule they do not operate effectively in urban areas.
13
http://en.wikipedia.org/wiki/Geothermal_heat_pump
15
WHO Expert Committee on Specifications for Pharmaceutical Preparations
16
WHO Technical Report Series, No. 992, Annex 5
Supplement 1
Bibliography
Assi TM, Brown ST, Kone S, Norman BA, Djibo A, Connor DL, et al.
Removing the regional level from the Niger vaccine supply chain. Vaccine.
2013;31(26):282834. doi: 10.1016/j (http://www.sciencedirect.com/science/
article/pii/S0264410X13004301, accessed 6 February 2015).
Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA,
et al. Augmenting transport versus increasing cold storage to improve vaccine
supply chains. PLOS One;2013;8(5):e64303. doi:10.1371/journal.pone.0064303.
(http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.
pone.0064303#ack, accessed 6 February 2015).
Management Sciences for Health. MDS-3: Managing access to medicines
and health technologies. Arlington (VA): Kumarian Press; 2011 (http://
www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-
technologies, accessed 6 February 2015).
McCord J, Tien M, Sarley D. Guide to public health supply chain costing: a basic
methodology. Arlington (VA): USAID | DELIVER Project; 2013 (http://deliver.
jsi.com/dlvr_content/resources/allpubs/guidelines/SuppChaiCostMeth.pdf,
accessed 6 February 2015).
Rushton A, Croucher P, Baker P. The handbook of logistics and distribution
management: Third edition. London: The Chartered Institute of Logistics and
Transport (UK) and Kogan Page; 2008.
Toma H, Markvart T. PQS solar autonomy calculation method. Geneva: World
Health Organization; 2011 (http://apps.who.int/immunization_standards/
vaccine_quality/pqs_catalogue/catdocumentation.aspx?id_cat=17).
USAID | Deliver Project. Supply chain costing tool. 2013 (http://deliver.jsi.
com/dlvr_content/resources/allpubs/guidelines/SuppChaiCostManu.pdf,
accessed 6 February 2015).
World Health Organization. Model guidance for the storage and transport
of time- and temperature-sensitive pharmaceutical pharmaceuticals. In:
WHO Expert Committee on Specifications for Pharmaceutical Preparations:
forty-fifth report. Geneva: World Health Organization; 2011: Annex 9
(WHO Technical Report Series, No. 961; http://apps.who.int/medicinedocs/
documents/s18683en/s18683en.pdf, accessed 10 February 2015).
17
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Revision history
Date Change summary Reason for change Approved
18